| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +66.67% | -2.67% | -0.05% | -2.62% | -2.68% | — |
| 14d | 6 | +66.67% | -1.58% | +0.80% | -2.37% | -0.36% | — |
| 30d | 6 | +66.67% | -9.26% | -1.00% | -8.26% | -2.89% | — |
| 60d | 6 | +66.67% | -1.95% | +4.14% | -6.09% | -12.84% | — |
| 90d | 6 | +50.00% | +2.72% | +6.63% | -3.91% | -4.34% | — |
| 180d | 6(1 pending) | +40.00% | +10.02% | +13.96% | -3.95% | +12.49% | — |
| 1y | 6(1 pending) | +40.00% | +47.83% | +22.56% | +25.27% | +81.18% | — |
| 2y | 6(2 pending) | +50.00% | +118.01% | +23.93% | +94.09% | +94.75% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE10b5-1 10b5-1 plan | 5,000 | $20.50 | $102.5K | 406,775 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE10b5-1 10b5-1 plan | 5,000 | $19.00 | $95.0K | 411,775 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE10b5-1 10b5-1 plan | 11,000 | $18.00 | $198.0K | 416,775 | Jun 4, 2026 | Jun 8, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE Chief Commercial Officer, MRD | 41,338 | $13.17 | $544.4K | 427,775 | Mar 11, 2026 | Mar 13, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 59,375 | — | — | 406,613 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 62,500 | — | — | 469,113 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE Chief Commercial Officer, MRD | 26,023 | $6.98 | $181.6K | 347,238 | Mar 5, 2025 | Mar 6, 2025 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 119,971 | — | — | 373,261 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 180,029 | — | — | 180,029 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE Chief Commercial Officer, MRD | 5,000 | — | — | 0 | Oct 8, 2024 | Oct 10, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE Chief Commercial Officer, MRD | 5,000 | $1.98 | $9.9K | 253,290 | Oct 8, 2024 | Oct 10, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE Chief Commercial Officer, MRD | 6,016 | $3.43 | $20.6K | 255,265 | Mar 5, 2024 | Mar 6, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE Chief Commercial Officer, MRD | 6,975 | $3.44 | $24.0K | 248,290 | Mar 5, 2024 | Mar 6, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 132,979 | — | — | 261,281 | Mar 4, 2024 | Mar 6, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 199,549 | — | — | 199,549 | Mar 4, 2024 | Mar 6, 2024 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 9,158 | — | — | 9,158 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 22,894 | — | — | 22,894 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, Diagnostics, clonoSEQ | 25,000 | $1.98 | $49.5K | 25,000 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Diagnostics, clonoSEQ | 25,000 | $55.00 | $1.38M | 0 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Diagnostics, clonoSEQ | 25,000 | — | — | 30,000 | Dec 10, 2020 | Dec 11, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, Diagnostics, clonoSEQ | 10,000 | $1.98 | $19.8K | 10,000 | Sep 29, 2020 | Oct 1, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Diagnostics, clonoSEQ | 10,000 | — | — | 55,000 | Sep 29, 2020 | Oct 1, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Diagnostics, clonoSEQ | 10,000 | $50.00 | $500.0K | 0 | Sep 29, 2020 | Oct 1, 2020 ↗ | View → |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 20,000 | — | — | 20,000 | Aug 13, 2020 | Aug 14, 2020 ↗ | View → |